MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-500-18 |
Device Problems
Break (1069); Material Deformation (2976)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/09/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report the pipeline was tracked through the anatomy to the tip of the phenom catheter.It was noticed that the distal wire was crimped.The physician decided to deliver the pipeline and during delivery the distal end of the wire was fractured.A gooseneck snare was used and the fractured tip was removed from the patient.The pipeline was used for an indication that is approved and the pipeline and any accessory devices were prepared as indicated in the ifu.No patient symptoms or further complications were reported as a result of this event. the patient was undergoing surgery for treatment of a saccular, unruptured aneurysm of the internal carotid/ophthalmic artery with a max diameter of 11 mm and a 5 mm neck diameter.The landing zone was 4mm at the distal end and 5.2 mm at the proximal end.It was noted the patient's vessel tortuosity was severe.Dapt was administered.Pru level was 117.The angiographic result post procedure was the vessel was patent.Aneurysm was secure with coils and pipeline.Ancillary devices include a 6f shuttle 90 cm sheath, phenom 27 microcatheter, synchro 14 guidewire, and 8x20, 8x30, 7x30, 7x30, 7x20, 6x30 target 360 soft coils.
|
|
Manufacturer Narrative
|
H3: analysis of the ped2-500-18 (lot# b348199) found that the pipeline flex embolization device proximal assembly was not returned.The tip coil was found to be detached and returned.The dps sleeves appeared to be in good condition.The tip coil was found to be damaged.The pipeline braid was not returned.Based on the device analysis and reported information, the customer¿s report of ¿pushwire break/separation¿ was unable to be confirmed as the pipeline flex proximal assembly was not returned.Based on the device analysis and reported information, the customer¿s report of ¿pushwire kink/damage¿ was unable to be confirmed.The root cause could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|